rs150762709

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS2_SupportingBS1

This summary comes from the ClinGen Evidence Repository: The NM_000536.4:c.22G>A variant in RAG2 is a missense variant predicted to cause substitution of valine by isoleucine at amino acid 8 (p.Val8Ile). This variant has a population max filtering allele frequency of 0.004397 in gnomAD, which is above the threshold for BS1 set by the ClinGen SCID VCEP for RAG2 (>0.00195). This variant has not been identified in individuals with SCID, though it has been identified in one individual with CID (PMID:28769923) who carried a co-occurring variant p.D200H (phase unknown, p.D200H not curated by ClinGen SCID VCEP). In addition, this variant is present in 5 homozygotes in gnomAD (BS2_Supporting). In summary, this variant is classified as a Likely Benign for autosomal recessive SCID based on the ACMG criteria applied: BS1 and BS2_Supporting as specified by the ClinGen SCID VCEP (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA293055/MONDO:0000573/124

Frequency

Genomes: 𝑓 0.0031 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 21 hom. )

Consequence

RAG2
NM_000536.4 missense

Scores

3
16

Clinical Significance

Likely benign reviewed by expert panel B:11

Conservation

PhyloP100: 1.29
Variant links:
Genes affected
RAG2 (HGNC:9832): (recombination activating 2) This gene encodes a protein that is involved in the initiation of V(D)J recombination during B and T cell development. This protein forms a complex with the product of the adjacent recombination activating gene 1, and this complex can form double-strand breaks by cleaving DNA at conserved recombination signal sequences. The recombination activating gene 1 component is thought to contain most of the catalytic activity, while the N-terminal of the recombination activating gene 2 component is thought to form a six-bladed propeller in the active core that serves as a binding scaffold for the tight association of the complex with DNA. A C-terminal plant homeodomain finger-like motif in this protein is necessary for interactions with chromatin components, specifically with histone H3 that is trimethylated at lysine 4. Mutations in this gene cause Omenn syndrome, a form of severe combined immunodeficiency associated with autoimmune-like symptoms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BS1
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RAG2NM_000536.4 linkc.22G>A p.Val8Ile missense_variant 2/2 ENST00000311485.8 NP_000527.2 P55895

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RAG2ENST00000311485.8 linkc.22G>A p.Val8Ile missense_variant 2/21 NM_000536.4 ENSP00000308620.4 P55895

Frequencies

GnomAD3 genomes
AF:
0.00306
AC:
465
AN:
152200
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00235
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00445
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.00351
AC:
873
AN:
248640
Hom.:
4
AF XY:
0.00345
AC XY:
466
AN XY:
135074
show subpopulations
Gnomad AFR exome
AF:
0.000463
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.0167
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00157
Gnomad FIN exome
AF:
0.00277
Gnomad NFE exome
AF:
0.00473
Gnomad OTH exome
AF:
0.00413
GnomAD4 exome
AF:
0.00458
AC:
6689
AN:
1459636
Hom.:
21
Cov.:
30
AF XY:
0.00448
AC XY:
3253
AN XY:
726320
show subpopulations
Gnomad4 AFR exome
AF:
0.000658
Gnomad4 AMR exome
AF:
0.00116
Gnomad4 ASJ exome
AF:
0.0162
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00160
Gnomad4 FIN exome
AF:
0.00272
Gnomad4 NFE exome
AF:
0.00501
Gnomad4 OTH exome
AF:
0.00507
GnomAD4 genome
AF:
0.00306
AC:
466
AN:
152318
Hom.:
3
Cov.:
32
AF XY:
0.00266
AC XY:
198
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000601
Gnomad4 AMR
AF:
0.00242
Gnomad4 ASJ
AF:
0.0167
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00186
Gnomad4 FIN
AF:
0.00235
Gnomad4 NFE
AF:
0.00445
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.00493
Hom.:
4
Bravo
AF:
0.00291
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00419
AC:
36
ExAC
AF:
0.00313
AC:
380
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00387
EpiControl
AF:
0.00397

ClinVar

Significance: Likely benign
Submissions summary: Benign:11
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2024RAG2: BS2 -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 26, 2023- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Histiocytic medullary reticulosis Benign:3
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMay 18, 2021- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Recombinase activating gene 2 deficiency Benign:1
Likely benign, reviewed by expert panelcurationClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGenNov 14, 2023The NM_000536.4:c.22G>A variant in RAG2 is a missense variant predicted to cause substitution of valine by isoleucine at amino acid 8 (p.Val8Ile). This variant has a population max filtering allele frequency of 0.004397 in gnomAD, which is above the threshold for BS1 set by the ClinGen SCID VCEP for RAG2 (>0.00195). This variant has not been identified in individuals with SCID, though it has been identified in one individual with CID (PMID: 28769923) who carried a co-occurring variant p.D200H (phase unknown, p.D200H not curated by ClinGen SCID VCEP). In addition, this variant is present in 5 homozygotes in gnomAD (BS2_Supporting). In summary, this variant is classified as a Likely Benign for autosomal recessive SCID based on the ACMG criteria applied: BS1 and BS2_Supporting as specified by the ClinGen SCID VCEP (VCEP specifications version 1). -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.25
T;T;.;.
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.057
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.61
.;T;T;T
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.0070
T;T;T;T
MetaSVM
Uncertain
-0.035
T
MutationAssessor
Benign
1.4
L;L;.;.
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.030
N;.;N;N
REVEL
Benign
0.17
Sift
Benign
0.12
T;.;T;T
Sift4G
Benign
0.14
T;T;.;.
Polyphen
0.0010
B;B;.;.
Vest4
0.079
MVP
0.88
MPC
0.31
ClinPred
0.010
T
GERP RS
4.8
Varity_R
0.058
gMVP
0.096

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150762709; hg19: chr11-36615697; COSMIC: COSV57558472; COSMIC: COSV57558472; API